Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 12666
Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718891(US20250042914, Example 17)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718907(US20250042914, Example 33)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718906(US20250042914, Example 32)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718905(US20250042914, Example 31)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718899(US20250042914, Example 25)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718898(US20250042914, Example 24)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718896(US20250042914, Example 22)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718895(US20250042914, Example 21)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718893(US20250042914, Example 19)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718875(US20250042914, Example 1)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718890(US20250042914, Example 16)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718888(US20250042914, Example 14)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718886(US20250042914, Example 12)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718876(US20250042914, Example 2)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718877(US20250042914, Example 3)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718878(US20250042914, Example 4)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718879(US20250042914, Example 5)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718880(US20250042914, Example 6)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718881(US20250042914, Example 7)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718882(US20250042914, Example 8)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718883(US20250042914, Example 9)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718887(US20250042914, Example 13)
Affinity DataIC50: 50nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718894(US20250042914, Example 20)
Affinity DataIC50: 75nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718892(US20250042914, Example 18)
Affinity DataIC50: 75nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718902(US20250042914, Example 28)
Affinity DataIC50: 75nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718903(US20250042914, Example 29)
Affinity DataIC50: 75nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718904(US20250042914, Example 30)
Affinity DataIC50: 75nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718885(US20250042914, Example 11)
Affinity DataIC50: 75nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718897(US20250042914, Example 23)
Affinity DataIC50: 100nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718884(US20250042914, Example 10)
Affinity DataIC50: 100nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718900(US20250042914, Example 26)
Affinity DataIC50: 100nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718901(US20250042914, Example 27)
Affinity DataIC50: 100nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent

Target1-phosphatidylinositol 3-phosphate 5-kinase(Human)
Hanmi Pharm. Co.

US Patent
LigandPNGBDBM718889(US20250042914, Example 15)
Affinity DataIC50: 100nMAssay Description:For each of the compounds prepared in Examples 1 to 33, the PIKfyve enzyme inhibitory activity was measured by using a QS S Assis PIKFYVE (PIP5K3)_AD...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/12/2025
Entry Details
Go to US Patent